Holger Weis

Insider Reports History

Identity Names, identifiers, and filing context for this profile. 1 identity field
Reporting-owner location
Boston, MA
SEC source record Original filing metadata and source links for verification. 1 source field
Latest reporting-owner signature
/s/ Holger Weis
Source evidence Original filing metadata and source links for verification. 1 source field
Transaction source note
Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Holger Weis

Form 4 holding Director

JUPITER NEUROSCIENCES, INC.

Security class
Convertible Notes
Shares / value
10,781
Estimated value
$30,187
Report date
22 Jan 2025
Price
$2.80
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Chief Executive Officer

Alaunos Therapeutics, Inc.

Security class
Employee Stock Option (right to buy)
Shares / value
13,676
Estimated value
Report date
18 Aug 2025
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

JUPITER NEUROSCIENCES, INC.

Security class
Common Stock, par value $0.0001 per share
Shares / value
10,781
Estimated value
Report date
22 Jan 2025
Price
Ownership
Direct

Insider Reports Filed by Holger Weis

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .